SCHEMBL1102934

SCHEMBL1102934

c1ccc2c(c1)-c1cccc3c(-c4c5ccccc5c(-c5ccc6c7c(cccc57)-c5ccccc5-6)c5ncccc45)ccc-2c13

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
KDM4E B2RXH2 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.37
TSHR P16473 2/20 0.37
HIF1A Q16665 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP1 P29466 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HSP90AA1 P07900 2/20 0.36
NPC1 O15118 2/20 0.36
MAPT P10636 3/20 0.36
PABPC1 P11940 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PARP1 P09874 1/20 0.36
HTT P42858 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103232 0.94 ALDH1A1 (0.40) CRHBPCRHR2KEAP1NFE2L2KDM4E
SCHEMBL1103041 0.91 ENPP1 (0.38) CRHBPCRHR2KEAP1NFE2L2KDM4E
SCHEMBL1103090 0.85 KDM4E (0.45) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL1103173 0.84 TSHR (0.38) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL1102865 0.83 KDM4E (0.47) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL1102733 0.83 CCR1 (0.40) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL1103233 0.82 KDM4E (0.39) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL1103195 0.82 KDM4E (0.43) KDM4EL3MBTL1TSHRHIF1AALDH1A1
SCHEMBL3418742 0.82 KEAP1 (0.58) CRHBPCRHR2KEAP1NFE2L2KDM4E
SCHEMBL1102881 0.81 CYP11B2 (0.51) KDM4EL3MBTL1TSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 CRHBP 4736/4885CRHR2 3997/4885KEAP1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.